Literature DB >> 20573179

Survival with Rett syndrome: comparing Rett's original sample with data from the Australian Rett Syndrome Database.

Michael Freilinger1, Ami Bebbington, Ines Lanator, Nick De Klerk, Daniela Dunkler, Rainer Seidl, Helen Leonard, Gabriel M Ronen.   

Abstract

AIM: rett syndrome is a severe neurodevelopmental disorder that typically affects females. Little is known about the natural history and survival time of these females.
METHOD: we compared the survival of all Austrian female participants from Rett's historical cohort (1966) with that of affected females registered in the Australian Rett Syndrome Database. The analysis included both Kaplan-Meier analysis and a log-rank test for equality of survivor functions.
RESULTS: of females in the original Austrian group, three are still alive. The median age at death was 13 years 4.8 months. The probability of survival up to the age of 25 years was 21%, compared with 71% in the Australian cohort (p<0.001). We found no practical or statistically significant differences in survival between the various birth year groups within the Australian cohort.
INTERPRETATION: our data indicate that survival of females with Rett syndrome has improved since the late 1960s but that there has been shown no change in survival over the last 30 years, possibly because the follow-up time has been too short.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573179     DOI: 10.1111/j.1469-8749.2010.03716.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  14 in total

Review 1.  Complexities of Rett syndrome and MeCP2.

Authors:  Rodney C Samaco; Jeffrey L Neul
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  The Changing Face of Survival in Rett Syndrome and MECP2-Related Disorders.

Authors:  Daniel C Tarquinio; Wei Hou; Jeffrey L Neul; Walter E Kaufmann; Daniel G Glaze; Kathleen J Motil; Steven A Skinner; Hye-Seung Lee; Alan K Percy
Journal:  Pediatr Neurol       Date:  2015-06-26       Impact factor: 3.372

3.  Autonomic dysfunction and sudden death in patients with Rett syndrome: a systematic review

Authors:  Jatinder Singh; Evamaria Lanzarini; Paramala Santosh
Journal:  J Psychiatry Neurosci       Date:  2020-05-01       Impact factor: 6.186

4.  The relationship between MECP2 mutation type and health status and service use trajectories over time in a Rett syndrome population.

Authors:  Deidra Young; Ami Bebbington; Nick de Klerk; Carol Bower; Lakshmi Nagarajan; Helen Leonard
Journal:  Res Autism Spectr Disord       Date:  2011-01

Review 5.  Clinical and biological progress over 50 years in Rett syndrome.

Authors:  Helen Leonard; Stuart Cobb; Jenny Downs
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

6.  Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows.

Authors:  Hélène Cheval; Jacky Guy; Cara Merusi; Dina De Sousa; Jim Selfridge; Adrian Bird
Journal:  Hum Mol Genet       Date:  2012-05-31       Impact factor: 6.150

7.  Rett Syndrome.

Authors:  E E J Smeets; K Pelc; B Dan
Journal:  Mol Syndromol       Date:  2012-04-16

8.  [Key-topics in Austrian Child and Adolescent Psychiatry 2007-2017].

Authors:  Andreas Karwautz; Cvetka F Lipuš; Martin Fuchs
Journal:  Neuropsychiatr       Date:  2017-08-30

Review 9.  Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

Authors:  K R Sabitha; Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2020-12-25       Impact factor: 8.989

10.  Twenty years of surveillance in Rett syndrome: what does this tell us?

Authors:  Alison Anderson; Kingsley Wong; Peter Jacoby; Jenny Downs; Helen Leonard
Journal:  Orphanet J Rare Dis       Date:  2014-06-19       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.